[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10444-10445]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03533]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-R-267 and CMS-10396]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by April 24, 2020.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
http://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number ___, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to [email protected].
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
[[Page 10445]]
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-R-267 Medicare Plus Choice Program Requirements Referenced in 42
CFR 422.000--422.700
CMS-10396 Medication Therapy Management Program Improvements--
Standardized Format
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision with change of
a currently approved collection; Title of Information Collection:
Medicare Plus Choice Program Requirements Referenced in 42 CFR 422.000-
422.700; Use: The information collection requirements are mandated by
42 CFR part 422. Section 4001 of the Balanced Budget Act of 1997 (BBA)
added sections 1851 through 1859 to the Social Security Act to
establish the Managed Care program. The Medicare, Medicaid, and SCHIP
Benefits Improvement Act and Protection Act of 2000, Public Law 106-554
added requirements to the Managed Care program. The Medicare
Prescription Drug, Improvement, and Modernization Act of 2003 (Pub. L.
108-173) created the Medicare Advantage program.
A major goal of the Medicare Advantage program is to provide ease
of access for Original Medicare beneficiaries who wish to enroll in a
Medicare Advantage program. Certain populations of beneficiaries such
as the dually eligible population (those beneficiaries enrolled in both
Medicaid and Medicare) have grown since the program was created and
these populations require more flexibilities.
MA organizations (formerly M+C organizations) and potential MA
organizations (applicants) use the information collected based on the
regulations at 42 CFR part 422 to comply with the application
requirements and the MA contract requirements. CMS uses the information
collected based on the regulations at 42 CFR part 422 to approve
contract applications, monitor compliance with contract requirements,
make proper payment to MA organizations, determine compliance with the
new prescription drug benefit requirements established by the MMA, and
to ensure that correct information is disclosed to Medicare
beneficiaries, both potential enrollees and enrollees.
Information supplied by organizations is used to determine
eligibility for contracting with CMS, for determining compliance with
contract requirements, and for calculating proper payment to the
organizations. Information supplied by Medicare beneficiaries is used
to determine eligibility to enroll in the M+C organization and to
determine proper payment to the organization that enrolled the
beneficiary. Separate OMB approval was sought for each form as
required.
The information collection request also incorporates the new
minimum criteria for dual eligible special needs plans (D-SNPs) to
integrate Medicare and Medicaid benefits detailed in Section 50311(b)
of the Bipartisan Budget Act of 2018 and set forth in in Final rule
(CMS-4185-F, RIN 0938-AT59) for CY2020 and 2021. The integration
requirements improve care coordination, quality of care, and
beneficiary satisfaction while reducing administrative burden. Form
Number: CMS-R-267 (OMB control number: 0938-0753); Frequency: Yearly;
Affected Public: State, Local, or Tribal Governments; Number of
Respondents: 6,727,508; Total Annual Responses: 6,750,814; Total Annual
Hours: 1,848,180. (For policy questions regarding this collection
contact Marna Metcalf Akbar at 410-786-8251.)
2. Type of Information Collection Request: Revision with change of
a currently approved collection; Title of Information Collection:
Medication Therapy Management Program Improvements--Standardized
Format; Use: The Medicare Modernization Act of 2003 (MMA) under title
42 CFR part 423, subpart D, establishes the requirements that Part D
sponsors, an organization which has one or more contract(s) with CMS to
provide Part D benefits to Medicare beneficiaries, must meet with
regard to cost control and quality improvement including requirements
for medication therapy management (MTM) programs. MTM is a patient-
centric and comprehensive approach to improve medication use, reduce
the risk of adverse events, and improve medication adherence. At
minimum, a Part D sponsors' MTM program must offer to its enrollees an
annual comprehensive medication review with written summaries,
quarterly targeted medication reviews, and follow-up interventions for
both beneficiaries and prescribers when necessary.
Information collected by Part D MTM programs as required by the
Standardized Format for the CMR summary, which is used by beneficiaries
or their authorized representatives, caregivers, and their healthcare
providers to improve medication use and achieve better healthcare
outcomes. The Standardized Format must comply with applicable industry
standards for medication therapy management and electronic data
interchange, and should enable CMR data elements to be captured for
clinical, reporting or measurement purposes.
After a CMR is performed, the sponsor creates and sends a summary
of the CMR to the beneficiary that includes a medication action plan
and personal medication list using the Standardized Format. The
information users are beneficiaries or their authorized
representatives, caregivers, and their healthcare providers as stated
in this section. Form Number: CMS-10396 (OMB control number: 0938-
1154); Frequency: Yearly; Affected Public: State, Local, or Tribal
Governments; Number of Respondents: 735; Total Annual Responses:
2,173,254; Total Annual Hours: 1,448,908. (For policy questions
regarding this collection contact Victoria Dang at 410-786-3991.)
Dated: February 18, 2020.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2020-03533 Filed 2-21-20; 8:45 am]
BILLING CODE 4120-01-P